Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials

被引：8
作者：
Wang, Jing [1 ]
Zhan, Ping [2 ]
Ouyang, Jian [1 ]
Chen, Bing [1 ]
Zhou, Rongfu [1 ]
机构：
[1] Nanjing Univ, Affiliated DrumTower Hosp, Dept Hematol, Sch Med, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Resp Med, Nanjing 210008, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2009年 / 50卷 / 03期
关键词：
ELDERLY-PATIENTS; DOUBLE-BLIND; GUIDELINES; THERAPY; OLDER;
D O I：
10.1080/10428190802654501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：457 / 459
页数：3
相关论文
共 15 条
  • [1] Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
    Amadori, S
    Suciu, S
    Jehn, U
    Stasi, R
    Thomas, X
    Marie, JP
    Muus, P
    Lefrère, F
    Berneman, Z
    Fillet, G
    Denzlinger, C
    Willemze, R
    Leoni, P
    Leone, G
    Casini, M
    Ricciuti, F
    Vignetti, M
    Beeldens, F
    Mandelli, F
    De Witte, T
    [J]. BLOOD, 2005, 106 (01) : 27 - 34
  • [2] A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS
    BERLIN, JA
    LAIRD, NM
    SACKS, HS
    CHALMERS, TC
    [J]. STATISTICS IN MEDICINE, 1989, 8 (02) : 141 - 151
  • [3] Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia
    Bradstock, K
    Matthews, J
    Young, G
    Lowenthal, R
    Baxter, H
    Arthur, C
    Bashford, J
    Brighton, T
    Cannell, P
    Dunlop, L
    Durrant, S
    Enno, A
    Eliadis, P
    Gill, D
    Gillett, A
    Gottlieb, D
    Januszewicz, H
    Joshua, D
    Leahy, M
    Schwarer, A
    Taylor, K
    [J]. LEUKEMIA, 2001, 15 (09) : 1331 - 1338
  • [4] Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98
    Creutzig, Ursula
    Zimmermann, Martin
    Lehrnbecher, Thomas
    Graf, Norbert
    Hermann, Johann
    Niemeyer, Charlotte M.
    Reiter, Alfred
    Ritter, Joerg
    Dworzak, Michael
    Stary, Jan
    Reinhardt, Dirk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4499 - 4506
  • [5] A CONTROLLED-STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS AFTER TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA
    DOMBRET, H
    CHASTANG, C
    FENAUX, P
    REIFFERS, J
    BORDESSOULE, D
    BOUABDALLAH, R
    MANDELLI, F
    FERRANT, A
    AUZANNEAU, G
    TILLY, H
    YVER, A
    DEGOS, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25) : 1678 - 1683
  • [6] A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study (9031)
    Godwin, JE
    Kopecky, KJ
    Head, DR
    Willman, CL
    Leith, CP
    Hynes, HE
    Balcerzak, SP
    Appelbaum, FR
    [J]. BLOOD, 1998, 91 (10) : 3607 - 3615
  • [7] Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial
    Goldstone, AH
    Burnett, AK
    Wheatley, K
    Smith, AG
    Hutchinson, RM
    Clark, RE
    [J]. BLOOD, 2001, 98 (05) : 1302 - 1311
  • [8] A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia
    Heil, G
    Hoelzer, D
    Sanz, MA
    Lechner, K
    Yin, JAL
    Papa, G
    Noens, L
    Szer, J
    Ganser, A
    OBrien, C
    Matcham, J
    [J]. BLOOD, 1997, 90 (12) : 4710 - 4718
  • [9] LIESCHKE GJ, 1992, NEW ENGL J MED, V327, P99
  • [10] Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
    Löwenberg, B
    van Putten, W
    Theobald, M
    Gmür, J
    Verdonck, L
    Sonneveld, P
    Fey, M
    Schouten, H
    de Greef, G
    Ferrant, A
    Kovacsovics, T
    Gratwohl, A
    Daenen, S
    Huijgens, P
    Boogaerts, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 743 - 752
12